Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jul 15, 2011

Premium

Caprotec Bioanalytics this week appointed Marc Voigt as managing director, chief financial officer, and chief operating officer.

Voigt comes to the company from Medical Enzymes where he was chief financial officer and chief business officer. Prior to that he was chief financial officer and chief business officer at Revotar Biopharmaceuticals.


Thermo Fisher Scientific said this week it has elected Lars Rebien Sorensen to its board of directors.

Sorensen is president and CEO of healthcare company Novo Nordisk. He is also a member of the supervisory board of Bertelsmann and a director of Dong Energy.


Robert McBurney this week was named CEO of the Accelerated Cure Project for Multiple Sclerosis.

Formerly the CEO of Cambridge Neuroscience, McBurney has held senior positions at firms including BG Medicine and TheraGenetics and is the co-founder of Differential Proteomics and Optimal Medicine.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.